Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Glutamate [NMDA] receptor subunit epsilon 2 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus multilocularis | glutamate (NMDA) receptor subunit | Get druggable targets OG5_129290 | All targets in OG5_129290 |
Schistosoma mansoni | glutamate receptor NMDA | Get druggable targets OG5_129290 | All targets in OG5_129290 |
Echinococcus granulosus | glutamate NMDA receptor subunit | Get druggable targets OG5_129290 | All targets in OG5_129290 |
Schistosoma japonicum | ko:K05314 glutamate receptor, ionotropic, N-methyl-D-aspartate 2, invertebrate, putative | Get druggable targets OG5_129290 | All targets in OG5_129290 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | Family T1, proteasome beta subunit, threonine peptidase | 0.0079 | 1 | 1 |
Toxoplasma gondii | proteasome subunit beta type, putative | 0.0079 | 1 | 1 |
Leishmania major | proteasome beta 5 subunit, putative | 0.0079 | 1 | 1 |
Loa Loa (eye worm) | proteasome A-type and B-type family protein | 0.0079 | 1 | 1 |
Mycobacterium leprae | proteasome (beta subunit) PrcB | 0.0079 | 1 | 0.5 |
Plasmodium vivax | proteasome subunit beta type-5, putative | 0.0079 | 1 | 1 |
Entamoeba histolytica | proteasome subunit beta type 5 precursor, putative | 0.0079 | 1 | 1 |
Trypanosoma brucei | proteasome subunit beta type-5, putative | 0.0079 | 1 | 1 |
Echinococcus granulosus | proteasome prosome macropain subunit beta | 0.0035 | 0.0704 | 0.0704 |
Echinococcus granulosus | proteasome prosome macropain | 0.0079 | 1 | 1 |
Schistosoma mansoni | glutamate receptor NMDA | 0.0076 | 0.9226 | 0.9167 |
Echinococcus multilocularis | proteasome (prosome, macropain) | 0.0079 | 1 | 1 |
Giardia lamblia | Proteasome subunit beta type 5 precursor | 0.0079 | 1 | 1 |
Echinococcus granulosus | glutamate NMDA receptor subunit | 0.0076 | 0.9226 | 0.9226 |
Trypanosoma cruzi | proteasome subunit beta type-5, putative | 0.0079 | 1 | 1 |
Mycobacterium tuberculosis | Proteasome beta subunit PrcB; assembles with alpha subunit PrcA. | 0.0079 | 1 | 0.5 |
Plasmodium falciparum | proteasome subunit beta type-5 | 0.0079 | 1 | 1 |
Schistosoma mansoni | proteasome catalytic subunit 3 (T01 family) | 0.0079 | 1 | 1 |
Echinococcus multilocularis | proteasome (prosome, macropain) subunit, beta | 0.0035 | 0.0704 | 0.0704 |
Trypanosoma cruzi | proteasome subunit beta type-5, putative | 0.0079 | 1 | 1 |
Echinococcus multilocularis | glutamate (NMDA) receptor subunit | 0.0076 | 0.9226 | 0.9226 |
Mycobacterium ulcerans | proteasome PrcB | 0.0079 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 116 nM | Displacement of [3H]CP101,606 from NR2B in rat forebrain P2 membrane | ChEMBL. | 17768047 |
IC50 (binding) | = 116 nM | Displacement of [3H]CP101,606 from NR2B in rat forebrain P2 membrane | ChEMBL. | 17768047 |
Solubility | 0 | Solubility at pH 6.5 | ChEMBL. | 17768047 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.